The Endocrine Disruptor Page HomeSitemap
 

Chemical Safety Office
Evaluation and Licensing Division
Pharmaceutical and Food Safety Bureau
Ministry of Health, Labor and Welfare

Japanese

Last updated date: March 30, 2015
 

Home

 Advisory Committee

   Actions

     Scheme

     Overview

FAQs

Bisphenol A

Reports, etc.

Related reports

Links

Contact


 
Reports

Advisory Committee on Health Effects of Endocrine Disruptors
The Supplement II to the Intermediary Report
1.5.3

 

contents  Detailed contents  << prev  next >>

 

3. Guideline for risk communication concerning endocrine disruptors
This Guideline should be observed in preparation of the Endocrine Disruptor Website, leaflets and brochures for publicity, and publication of research results, including the Supplement II to Interim Report of the Advisory Committee on Health Effects of Environmental Disruptors.

(1) Contents
Selection of contents to be communicated should be made taking into account the wide variety of the audience in:

  • Age,
  • Knowledge already acquired, and
  • Urgency in information need.
Considering these factors, the following information should be provided.

[Basic information on the endocrine disruptor issue]

  • Background
  • Scientific findings
  • Explanation of frequently used terms
[Information on risk and its prediction]
  • Information on the evaluation of risk, including severity of hazard and exposure and high-risk populations, if any,
  • Information on risk management, e.g. measures for reducing risk.
The concept is risk is not properly understood by many. It is therefore advisable to begin the communication with explanation of basic concepts, such as risk, hazard, or risk identification. Widespread misunderstanding, if any, must be corrected by appropriate accounts.
 

contents  Detailed contents  << prev  next >>

 

 

About links, copyright, etc. Privacy policy

(C) 2005, 2016 Ministry of Health, Labour and Welfare, All Rights Reserved.